Peter Blume-Jensen

ACRV

Peter Blume-Jensen serves as President and CEO at Acrivon Therapeutics, Inc. Common Stock (ACRV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$164.2K

Total Sells

16 trades

$4.27M

Net Position

Net Seller

$4.11M

Companies Traded

ACRV

Active Period

Nov 2023 – Feb 2026

18 total trades

Most Recent

Sell ACRV

Feb 14, 2026 · $3.1K

Peter Blume-Jensen's Insider Trading at Acrivon Therapeutics, Inc. Common Stock (ACRV)

Buys

2 · $164.2K

Sells

16 · $4.27M

Total Shares Bought

98,000

Total Shares Sold

855,346

ACRV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 14, 2026	Sell	1,881	$1.63	$3.1K	0
Jan 16, 2026	Buy	49,000	$1.68	$82.1K	2,095,771
Jan 14, 2026	Buy	49,000	$1.68	$82.1K	0
Nov 21, 2025	Sell	19,904	$2.30	$45.8K	0
Nov 14, 2025	Sell	60,255	$2.24	$135.0K	0
Aug 21, 2025	Sell	19,905	$1.32	$26.3K	0
Aug 14, 2025	Sell	60,256	$1.39	$83.8K	0
May 21, 2025	Sell	19,904	$1.15	$22.9K	0
May 14, 2025	Sell	60,257	$1.14	$68.7K	0
Feb 21, 2025	Sell	19,904	$5.54	$110.3K	0
Feb 14, 2025	Sell	37,731	$5.42	$204.5K	0
Nov 21, 2024	Sell	19,910	$6.44	$128.2K	0
Nov 14, 2024	Sell	60,256	$7.92	$477.2K	0
Aug 21, 2024	Sell	79,616	$9.19	$731.7K	0
Aug 14, 2024	Sell	59,765	$7.02	$419.6K	0
May 14, 2024	Sell	54,918	$8.36	$459.1K	0
Feb 14, 2024	Sell	41,861	$3.40	$142.3K	0
Nov 14, 2023	Sell	239,023	$5.08	$1.21M	0